Cim, LLC Incyte Corp Transaction History

Cim, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$73.04 - $95.72 $1.05 Million - $1.37 Million	-14,335 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$72.82 - $86.52 $4,806 - $5,710	-66 Reduced 0.46%	14,335 $1.06 Million
Q2 2019 Jul 22, 2019	BUY	$73.52 - $88.7 $540,813 - $652,477	7,356 Added 104.41%	14,401 $1.22 Million
Q1 2019 May 06, 2019	BUY	$63.56 - $88.17 $447,780 - $621,157	7,045 New	7,045 $606,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Cim, LLC, based on Form 13F filings with the SEC.

Stay updated on Cim, LLC with notifications on news.